Structure and biochemical effects of fenofibrate

This publication has 14 references indexed in Scilit:

• Fenofibrate treatment inhibits HMG-CoA reductase activity in mononuclear cells from hyperlipoproteinemic patients
  Atherosclerosis, 1985
• Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
• Kinetics of bovine milk lipoprotein lipase and the mechanism of enzyme activation by apolipoprotein C-II
  Biochemistry, 1983
• Effects of hypolipidemic drugs on hepatic CoA
  Biochemical Pharmacology, 1983
• Inactivation of 3-hydroxy-3-methylglutaryl coenzyme a reductase in cultured human blood mononuclear cells by procetofenic acid
  Pharmacological Research Communications, 1982
• Plasma lipid concentrations and lecithin:cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipol
  Metabolism, 1981
• Influence of procetofen on lipid metabolism in normocholesteremic rats
  Pharmacological Research Communications, 1979
• A comparison of clofibrate and its derivative methyl clofenapate
  Atherosclerosis, 1972
• Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein
  Biochemical and Biophysical Research Communications, 1972
• Modification of Metabolism and Distribution of Lipids by Ethyl Chlorophenoxyisobutyrate
  Nature, 1962